EGFR and neoplasm: CRISPR-mediated knockout of tumor suppressor genes, specially through the NHEJ process, has provided the opportunity to fabricate natural tumor cells.66 Guernet et al utilized a CRISPR-barcoding strategy to predict different mechanisms of resistance to EGFR inhibitors in NSCLC.